ArticleAmerican journal of cancer research2024

Polydatin ameliorates low-density lipoprotein cholesterol and lipid metabolism by downregulating proprotein convertase subtilisin/kexin type 9 (PCSK9) in triple-negative breast cancer with hyperlipidemia.

Min Liu et al.PubMed ↗Full text ↗

No numbers read from the abstract.